Novartis has option to acquire two future development-ready programs to augment its renal portfolio, a strategic area of focus for the company
This is in partnership with Mepro Pharmaceuticals which have successfully developed and commercialised the Albendazole Chewable formulation
Brimonidine Tartrate Ophthalmic Solution, 0.025% (OTC) is indicated to relieve redness of the eye due to minor eye irritations.
Based on AEGEAN Phase III trial results which showed Imfinzi-based regimen reduced the risk of recurrence, progression or death by 32% vs. neoadjuvant chemotherapy alone
Becomes the first rehab & recovery center in east India to earn NABH accreditation
Majority of organizations are looking to increase investments in public and hybrid cloud
He recently served as Senior Vice President of the API business at Shilpa Pharma Life Sciences for over 3 years
Third approval in China for AstraZeneca and Daiichi Sankyo’s Enhertu in less than two years
Our centers are performing as expected or even better
Subscribe To Our Newsletter & Stay Updated
